Finance

Lists
Why is 300199 down 2.62%?
Dive Deeper
300199:SHE
Hybio Pharmaceutical Co Ltd
CN¥24.88
-2.62%
(-0.67) 1D
Oct 14, 3:04:58 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300199...
Open
CN¥24.99
High
CN¥25.69
Low
CN¥24.63
Mkt. cap
22.57B
Avg. vol.
42.77M
Volume
63.38M
P/E ratio
171.94
52-wk high
CN¥27.70
52-wk low
CN¥16.23
EPS
CN¥0.14
Shares outstanding
883.24M
No. of employees
1K
Open
CN¥24.99
High
CN¥25.69
Low
CN¥24.63
Mkt. cap
22.57B
Avg. vol.
42.77M
Volume
63.38M
P/E ratio
171.94
52-wk high
CN¥27.70
52-wk low
CN¥16.23
EPS
CN¥0.14
Shares outstanding
883.24M
No. of employees
1K
News stories
From web sources and news partners
About Hybio Pharmaceutical Co Ltd
CEO-
Employees1.23K
Founded1998
Headquarters-
SectorPharmaceutical industry
Websitehybio.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
133.68M
283.23M
299.15M
389.14M
Cost of goods sold
64.65M
152.93M
105.01M
159.91M
Cost of revenue
64.65M
152.93M
105.01M
159.91M
Research and development expenses
27.93M
51.07M
30.87M
67.08M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
72.08M
59.40M
44.68M
41.35M
Operating expense
100.23M
121.55M
80.50M
111.54M
Total operating expenses
164.88M
274.48M
185.52M
271.45M
Operating income
-31.20M
8.75M
113.63M
117.69M
Other non operating income
-8.30M
-4.72M
-3.55M
-2.51M
EBT including unusual items
-72.35M
-23.38M
136.89M
116.86M
EBT excluding unusual items
-61.91M
-21.32M
134.01M
112.37M
Income tax expense
2.41M
12.35M
9.50M
8.62M
Effective tax rate
-3.34%
-52.81%
6.94%
7.37%
Other operating expenses
2.34M
4.18M
1.78M
3.82M
Net income
-74.12M
-34.78M
127.81M
108.89M
Net profit margin
-55.44%
-12.28%
42.73%
27.98%
Earnings per share
-
-
-
-
Interest and investment income
2.00M
-
224.45K
65.73M
Interest expense
-22.57M
-26.19M
-23.28M
-17.57M
Net interest expenses
-20.56M
-26.19M
-23.05M
48.15M
Depreciation and amortization charges
-
-
-
-
EBITDA
5.28M
41.34M
146.22M
157.41M
Gain or loss from assets sale
552.48K
-617.19K
-
-1.59M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps